# MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

> **NCT03718104** · — · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Opioid-use Disorder
- Neonatal Abstinence Syndrome
- Pregnancy, High Risk
- Alcohol Use Disorder

## Interventions

- **OTHER:** Pharmacokinetic analysis
- **OTHER:** Safety and Efficacy
- **GENETIC:** Genetic and epigenetic analysis
- **OTHER:** Breast milk analysis

## Key facts

- **NCT ID:** NCT03718104
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2024-05-08
- **Final completion:** 2024-05-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718104, "MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03718104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*